Dr. Amanda Malone - Keynote & Panelist

Dr. Malone has worked on the development of drug delivery systems for over 12 years.  She is the Chief Scientific Officer of Eupraxia Pharmaceuticals, a Victoria based biotech company that develops sustained release drug delivery systems targeting unmet medical needs.  Since its inception in 2012, she has guided Eupraxia Pharmaceutical’s scientific programs through the pre-clinical and manufacturing process and into the clinic.  The company now has 20 employees and is in the planning stages of a pivotal trial for their lead product, a treatment for arthritis.  Prior to joining Eupraxia, Dr. Malone was the Vice President and Chief Operating Officer of a drug delivery company that was granted over $9 million from the U.S. National Institute of Health and had 15 products under development.   She graduated with High Honors from Harvey Mudd College in Claremont, California with a degree in engineering and was the inaugural PhD student in Stanford’s Bioengineering Department. While at Stanford, she received both a National Science Foundation Fellowship and a Stanford BioX Graduate Fellowship.


Karen Lithgow